A high-density 3-dimensional culture model of human glioblastoma for rapid screening of therapeutic resistance.

Publication Year: 2023

DOI:
10.1016/j.bcp.2023.115410

PMCID:
PMC10840506

PMID:
36632958

Journal Information

Full Title: Biochem Pharmacol

Abbreviation: Biochem Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"The authors would like to thank members of the WPG and FAS labs for critical comments on the manuscript. WPG is funded by NC3Rs project NC/N002423/1. FAS is supported by MRC grant MR/S007709/1. The BRAIN Unit is funded by Welsh Government through Health and Care Research Wales (BRAIN Unit Infrastructure Award, Grant no: UA05 to WPG). J. Brown: Data curation, Formal analysis, Investigation, Methodology, Writing – original draft. M. Zaben: Supervision, Methodology, Writing – review & editing. C. Ormonde: Data curation, Validation. F. Sharouf: Data curation, Validation. R. Spencer: Data curation, Validation. H. Bhatt: Data curation, Validation. F.A. Siebzehnrubl: Supervision, Methodology, Funding acquisition, Writing – original draft, Writing – review & editing. W.P. Gray: Supervision, Methodology, Funding acquisition, Writing – review & editing."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025